var data={"name":"Substance use disorders","type":"SECTION","numTopics":"11,000","numSpecialties":"over 22","sections":[{"name":"Alcohol abuse","type":"SUBSECTION","items":[{"name":"Alcohol withdrawal: Epidemiology, clinical manifestations, course, assessment, and diagnosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=alcohol-withdrawal-epidemiology-clinical-manifestations-course-assessment-and-diagnosis"},{"name":"Ambulatory management of alcohol withdrawal","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=ambulatory-management-of-alcohol-withdrawal"},{"name":"Brief intervention for unhealthy alcohol and other drug use: Efficacy, adverse effects, and administration","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=brief-intervention-for-unhealthy-alcohol-and-other-drug-use-efficacy-adverse-effects-and-administration"},{"name":"Brief intervention for unhealthy alcohol and other drug use: Goals and components","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=brief-intervention-for-unhealthy-alcohol-and-other-drug-use-goals-and-components"},{"name":"Identification and management of unhealthy alcohol use in the perioperative period","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=identification-and-management-of-unhealthy-alcohol-use-in-the-perioperative-period"},{"name":"Nutritional status in patients with sustained heavy alcohol use","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=nutritional-status-in-patients-with-sustained-heavy-alcohol-use"},{"name":"Pharmacotherapy for alcohol use disorder","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pharmacotherapy-for-alcohol-use-disorder"},{"name":"Psychosocial treatment of alcohol use disorder","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=psychosocial-treatment-of-alcohol-use-disorder"},{"name":"Risky drinking and alcohol use disorder: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=risky-drinking-and-alcohol-use-disorder-epidemiology-pathogenesis-clinical-manifestations-course-assessment-and-diagnosis"}]},{"name":"Drug-specific abuse","type":"SUBSECTION","items":[{"name":"Approach to treatment of stimulant use disorder in adults","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=approach-to-treatment-of-stimulant-use-disorder-in-adults"},{"name":"Cannabis use and disorder: Clinical manifestations, course, assessment, and diagnosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=cannabis-use-and-disorder-clinical-manifestations-course-assessment-and-diagnosis"},{"name":"Cannabis use and disorder: Epidemiology, comorbidity, health consequences, and medico-legal status","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=cannabis-use-and-disorder-epidemiology-comorbidity-health-consequences-and-medico-legal-status"},{"name":"Cannabis use and disorder: Pathogenesis and pharmacology","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=cannabis-use-and-disorder-pathogenesis-and-pharmacology"},{"name":"Cannabis withdrawal: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=cannabis-withdrawal-epidemiology-pathogenesis-clinical-manifestations-course-assessment-and-diagnosis"},{"name":"Cocaine use disorder in adults: Epidemiology, pharmacology, clinical manifestations, medical consequences, and diagnosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=cocaine-use-disorder-in-adults-epidemiology-pharmacology-clinical-manifestations-medical-consequences-and-diagnosis"},{"name":"Medically supervised opioid withdrawal during treatment for addiction","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=medically-supervised-opioid-withdrawal-during-treatment-for-addiction"},{"name":"Methamphetamine use disorder: Epidemiology, clinical manifestations, course, assessment, and diagnosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=methamphetamine-use-disorder-epidemiology-clinical-manifestations-course-assessment-and-diagnosis"},{"name":"Opioid use disorder: Epidemiology, pharmacology, clinical manifestations, course, screening, assessment, and diagnosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=opioid-use-disorder-epidemiology-pharmacology-clinical-manifestations-course-screening-assessment-and-diagnosis"},{"name":"Opioid withdrawal: Clinical manifestations, course, assessment, and diagnosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=opioid-withdrawal-clinical-manifestations-course-assessment-and-diagnosis"},{"name":"Pharmacotherapy for opioid use disorder","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pharmacotherapy-for-opioid-use-disorder"},{"name":"Pharmacotherapy for stimulant use disorders in adults","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pharmacotherapy-for-stimulant-use-disorders-in-adults"},{"name":"Prescription drug misuse: Epidemiology, prevention, identification, and management","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=prescription-drug-misuse-epidemiology-prevention-identification-and-management"},{"name":"Prevention of lethal opioid overdose in the community","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=prevention-of-lethal-opioid-overdose-in-the-community"},{"name":"Psychosocial interventions for opioid use disorder","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=psychosocial-interventions-for-opioid-use-disorder"},{"name":"Psychosocial interventions for stimulant use disorder in adults","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=psychosocial-interventions-for-stimulant-use-disorder-in-adults"},{"name":"Screening for unhealthy use of alcohol and other drugs in primary care","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=screening-for-unhealthy-use-of-alcohol-and-other-drugs-in-primary-care"},{"name":"Treatment of cannabis use disorder","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-of-cannabis-use-disorder"},{"name":"Treatment of cannabis withdrawal","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-of-cannabis-withdrawal"}]},{"name":"Other","type":"SUBSECTION","items":[{"name":"Benzodiazepine use disorder: Epidemiology, pathogenesis, clinical manifestations, course, and diagnosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=benzodiazepine-use-disorder-epidemiology-pathogenesis-clinical-manifestations-course-and-diagnosis"},{"name":"Clinical assessment of substance use disorders","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-assessment-of-substance-use-disorders"},{"name":"Co-occurring schizophrenia and substance use disorder: Epidemiology, pathogenesis, clinical manifestations, course, assessment and diagnosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=co-occurring-schizophrenia-and-substance-use-disorder-epidemiology-pathogenesis-clinical-manifestations-course-assessment-and-diagnosis"},{"name":"Co-occurring substance use disorder and anxiety-related disorders in adults: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=co-occurring-substance-use-disorder-and-anxiety-related-disorders-in-adults-epidemiology-pathogenesis-clinical-manifestations-course-assessment-and-diagnosis"},{"name":"Contingency management for substance use disorders: Efficacy, implementation, and training","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=contingency-management-for-substance-use-disorders-efficacy-implementation-and-training"},{"name":"Contingency management for substance use disorders: Theoretical foundation, principles, assessment, and components","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=contingency-management-for-substance-use-disorders-theoretical-foundation-principles-assessment-and-components"},{"name":"Continuing care for addiction: Implementation","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=continuing-care-for-addiction-implementation"},{"name":"Continuing care for addiction: Indications, features, and efficacy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=continuing-care-for-addiction-indications-features-and-efficacy"},{"name":"Determining appropriate levels of care for treatment of substance use disorders","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=determining-appropriate-levels-of-care-for-treatment-of-substance-use-disorders"},{"name":"Insomnia in patients with a substance use disorder","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=insomnia-in-patients-with-a-substance-use-disorder"},{"name":"Motivational interviewing for substance use disorders","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=motivational-interviewing-for-substance-use-disorders"},{"name":"Permitted non-hormonal performance-enhancing substances","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=permitted-non-hormonal-performance-enhancing-substances"},{"name":"Pharmacotherapy for co-occurring schizophrenia and substance use disorder","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pharmacotherapy-for-co-occurring-schizophrenia-and-substance-use-disorder"},{"name":"Prohibited non-hormonal performance-enhancing drugs in sport","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=prohibited-non-hormonal-performance-enhancing-drugs-in-sport"},{"name":"Psychosocial interventions for co-occurring schizophrenia and substance use disorder","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=psychosocial-interventions-for-co-occurring-schizophrenia-and-substance-use-disorder"},{"name":"Substance use disorders in physicians: Assessment and treatment","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=substance-use-disorders-in-physicians-assessment-and-treatment"},{"name":"Substance use disorders in physicians: Epidemiology, clinical manifestations, identification, and engagement","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=substance-use-disorders-in-physicians-epidemiology-clinical-manifestations-identification-and-engagement"},{"name":"Treatment of co-occurring substance use disorder and anxiety-related disorders in adults","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-of-co-occurring-substance-use-disorder-and-anxiety-related-disorders-in-adults"}]}]}